Outpatient COVID-19 Investigational Vaccine Study (CIR 339) Astra Zeneca
The purpose of this study is to evaluate an investigational vaccine for the prevention of COVID-19 in adults.
The public now knows exactly how many infections these COVID-19 trials are planning for—and how many would trigger an interim analysis of early data. In an unprecedented but much-applauded move, the leading vaccine companies have released detailed trial protocols. Read full article